Sowell Financial Services’s Sarepta Therapeutics SRPT Stock Holding History

Sowell Financial Services’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-869	Closed	-$65K	–	2426
2021 Q1	$65K	Buy	869 +169	+24%	+$15.6K	﹤0.01%	1545
2020 Q4	$119K	Buy	700 +4	+0.6%	+$593	0.01%	1082
2020 Q3	$98K	Sell	696 -351	-34%	-$53.3K	﹤0.01%	981
2020 Q2	$168K	Buy	1,047 +587	+128%	+$79.9K	0.01%	788
2020 Q1	$45K	Sell	460 -1,054	-70%	-$120K	﹤0.01%	1099
2019 Q4	$195K	Buy	1,514 +1,314	+657%	+$133K	0.01%	722
2019 Q3	$15K	Buy	+200	New	+$23.6K	﹤0.01%	1396
2018 Q2	–	Sell	-4,409	Closed	-$346K	–	309
2018 Q1	$346K	Buy	+4,409	New	+$294K	0.09%	198
2017 Q1	–	Sell	-200	Closed	-$6K	–	524
2016 Q4	$6K	Buy	+200	New	+$8.03K	﹤0.01%	526

Other funds holding SRPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Sowell Financial Services's SRPT Position: Q2 2021 in Review

Sowell Financial Services sold out of Sarepta Therapeutics (SRPT) in Q2 2021, closing a stake of 869 shares — an estimated $65K sold.

Sowell Financial Services first reported a position in SRPT in Q4 2016 and held it in 9 quarters. The position peaked at $346K in Q1 2018. 331 funds tracked by Wall St. Rank hold SRPT as of Q2 2021.

Sowell Financial Services reported no remaining Sarepta Therapeutics position as of Q2 2021 after selling out during the quarter.
Sowell Financial Services sold 869 Sarepta Therapeutics shares in Q2 2021, an estimated $65K.
Sowell Financial Services first reported a position in Sarepta Therapeutics in Q4 2016 and held it in 9 quarters.
Sowell Financial Services's Sarepta Therapeutics position peaked at $346K in Q1 2018.
331 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.